Preformulation in Solid Dosage Form Development

Moji Christianah Adeyeye, Harry G. Brittain (Eds)

Verlag: CBS Publishers & Distributors Pvt. Ltd, 2008
ISBN 10: 0824758099 / ISBN 13: 9780824758097
Neu / Hardcover / Anzahl: > 20
Verkäufer BookVistas (New Delhi, DELHI, Indien)
Bei weiteren Verkäufern erhältlich
Alle  Exemplare dieses Buches anzeigen

Über dieses Buch

Leider ist dieses Exemplar nicht mehr verfügbar. Hier sehen Sie die besten Ergebnisse zur Suche nach Preformulation in Solid Dosage Form Development.

Beschreibung:

Covering every topic of critical importance to the preformulation stages of development, this guide equips those in the pharmaceutical industry with basic and applied principles for the characterization of new drug compounds and substances-considering the identification, stability, structure, and mechanisms of drug candidates during preformulation through Phase I of clinical trials. Catalog Copy During the onset of any clinical trial there are many factors and variables to consider. Funding, time restraints, and regulatory agency guidelines are factors that often influence which variables will be studied, leaving other important information out of the study. Preformulation in Solid Dosage Form Development covers every topic of critical importance to the preformulation stages of drug development. Serving as a handbook or stand-alone reference, this text equips those in academia and the pharmaceutical industry with both basic and applied principles for the characterization of drugs, excipients, and products, and deals with the issues relating to predictability, identification, and product development during preformulation stages through Phase I of clinical trials. With contributions from an international panel of experts in the field, this guide: outlines an updated preformulation program for modern drug development issues that includes particle morphology, characterization, thermal analysis, and solubility methods contains rational designs for the structure of formulation studies covers the importance of preformulation design using artificial neural networks and computational prediction techniques, and examines the concepts of preliminary-preformulation discusses the typical drug-excipient interactions that could occur during the course of development and methods of characterization includes novel methods to determine the physical and chemical stability of new formulations reviews the structure, content, and format of the preformulation report examines the significance of drug substance physiochemical properties, in regulatory quality by design Printed Pages: 596. Buchnummer des Verkäufers 45876

Über diesen Titel:

Inhaltsangabe:

During the onset of any clinical trial there are many factors and variables to consider. Funding, time restraints, and regulatory agency guidelines are factors that often influence which variables will be studied, leaving other important information out of the study. Preformulation in Solid Dosage Form Development covers every topic of critical importance to the preformulation stages of drug development. Serving as a handbook or stand-alone reference, this text equips those in academia and the pharmaceutical industry with both basic and applied principles for the characterization of drugs, excipients, and products, and deals with the issues relating to predictability, identification, and product development during preformulation stages through Phase I of clinical trials.

With contributions from an international panel of experts in the field, this guide:

  • outlines an updated preformulation program for modern drug development issues that includes particle morphology, characterization, thermal analysis, and solubility methods
  • contains rational designs for the structure of formulation studies
  • covers the importance of preformulation design using artificial neural networks and computational prediction techniques, and examines the concepts of preliminary-preformulation
  • discusses the typical drug-excipient interactions that could occur during the course of development and methods of characterization
  • includes novel methods to determine the physical and chemical stability of new formulations
  • reviews the structure, content, and format of the preformulation report
  • examines the significance of drug substance physiochemical properties, in regulatory quality by design

About the Author:

MOJI CHRISTIANAH ADEYEYE is currently a Professor of Pharmaceutics and Pharmaceutical Technology, a Fulbright Scholar, and a member of the graduate faculty at the School of Pharmacy, Duquesne University, Pittsburgh, Pennsylvania. She graduated from the University of Nigeria, Nsukka and the University of Georgia, Athens, where she earned her B.S., M.S., and Ph.D. respectively. Her research interests include, preformulation, drug/excipient characterization, delivery systems with a focus on bioavailability and bioequivalence of solid, semi-solid and liquid dosage forms (conventional, modified release). She has worked extensively on nonsteroidal anti-inflammatory drugs, steroids and excipients such as cyclodextrins, microcrystalline cellulose and silicified microcrystalline cellulose. She has published over 40 manuscripts and two patents and given over 100 scientific presentations. She was the past President of the Nigerian American Association of Pharmaceutical Scientists (NAAPS) and former Chair of the AAPS Preformulation Focus Group. She is the Founder and President of a non-profit organization―Drugs for AIDS and HIV Patients (DAHP) whose focus is to care and provide treatment for HIV/AIDS orphans and widows. She is a member of AAPS, APHA, CRS, AACP, AAUP and Christian Connections for International Health.

HARRY G. BRITTAIN is Founder of the Center for Pharmaceutical Physics, Milford, New Jersey. Previously, Dr. Brittain was Vice President for Pharmaceutical Development at Discovery Laboratories, Inc. He also served as Director of Pharmaceutical Development at Ohmeda Inc., and led a variety of groups within the Analytical R&D Department at Bristol-Myers Squibb Co. Dr. Brittain has authored more than 275 research publications and book chapters and has presented numerous invited lectures and short courses in pharmaceutics. He is editor of several books including Physical Characterization of Pharmaceutical Solids, Polymorphism in Pharmaceutical Solids, and Spectroscopy of Pharmaceutical Solids (Taylor & Francis, Inc.). Dr. Brittain is an Associate Editor for the Journal of Pharmaceutical Sciences, and a member of the editorial boards of Pharmaceutical Development and Technology, AAPS PharmSciTech, and Chirality. Dr. Brittain is a Fellow of the American Association of Pharmaceutical Scientists and of the Royal Institute of Chemistry, and a recipient of the AAPS Research Achievement Award in Analysis and Pharmaceutical Quality.

„Über diesen Titel“ kann sich auf eine andere Ausgabe dieses Titels beziehen.

Bibliografische Details

Titel: Preformulation in Solid Dosage Form ...
Verlag: CBS Publishers & Distributors Pvt. Ltd
Erscheinungsdatum: 2008
Einband: Hardcover
Zustand: New

Beste Suchergebnisse beim ZVAB

1.

Moji Christianah Adeyeye and Harry G. Brittain (Hrsg.)
Verlag: Informa Healthcare (2008)
Gebraucht Hardcover Anzahl: 1
Anbieter
Versandantiquariat Bolz
(Bonn, Deutschland)
Bewertung
[?]

Buchbeschreibung Informa Healthcare, 2008. 596 S., gr.8°, Hardcover 980 gr. befriedigender Zustand: Rücken mit einer kleinen Beschädigung, sonst sehr gut. Artikel-Nr. B5655

Weitere Informationen zu diesem Verkäufer | Frage an den Anbieter

Gebraucht kaufen
EUR 70,00
Währung umrechnen

In den Warenkorb

Versand: EUR 7,50
Von Deutschland nach USA
Versandziele, Kosten & Dauer